You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for Sonos, Inc. v. Google LLC (N.D. Cal. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Sonos, Inc. v. Google LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free and ⤷  Get Started Free .

Litigation summary and analysis for: Sonos, Inc. v. Google LLC (N.D. Cal. 2021)

Last updated: February 4, 2026

Litigation Summary and Analysis: Sonos, Inc. v. Google LLC | 3:21-cv-07559

Case Overview

Sonos, Inc. filed a patent infringement lawsuit against Google LLC in the Northern District of California on December 10, 2021. The case, docket number 3:21-cv-07559, involves allegations that Google infringed on Sonos patents related to wireless speaker technology. The lawsuit seeks injunctive relief, damages, and a declaration that Google’s products infringe Sonos patents.

Patent Claims and Allegations

Sonos asserts that Google’s smart speakers, including Google Assistant-enabled products, violate five patents related to:

  • Wireless multi-room audio technology
  • Synchronization across devices
  • User interface features for controlling multiple speakers
  • Power-efficient streaming methods
  • Audio data transmission and processing

The patents cited include US Patent Nos. 10,990,633; 10,997,322; 11,113,958; 11,138,096; and 11,476,950, all granted between 2021 and 2022.

Google's Response

Google denies infringement and argues that its products do not violate the patents. It contends that the patents are invalid based on prior art and that the asserted claims are indefinite or unsupported.

Litigation Timeline

  • December 2021: Complaint filed
  • January 2022: Google files motion to dismiss or to stay proceedings pending IPR considerations
  • March 2022: Court grants a stay for limited discovery, pending resolution of IPR petitions
  • June 2022: Google files petitions for inter partes review (IPR) with the Patent Trial and Appeal Board (PTAB) challenging the validity of the patents
  • December 2022: PTAB proceedings initiated; IPR trials underway

Patent Validity and IPR Proceedings

Google’s IPR petitions challenge the validity of all five patents. The PTAB is considering whether prior art references demonstrate that the patents are anticipated or obvious. Patent validity outcomes will significantly influence the scope and outcome of the litigation.

Key Legal Issues

  1. Patent Validity: The primary challenge facing Sonos is the validity of its patents in light of prior art. IPR proceedings aim to determine whether the patents meet patentability criteria.
  2. Infringement Claims: Sonos asserts that Google’s current product lineup infringes on the claims related to multi-room audio synchronization and control.
  3. Injunctive Relief and Damages: Sonos seeks injunctive relief to stop sales of infringing products, alongside monetary damages for ongoing infringement.

Market and Competitive Impact

The case is part of broader patent disputes between innovation-driven companies in the smart speaker and smart home space. A favorable ruling for Sonos could impose restrictions on Google’s product development and sales, potentially affecting market share.

Procedural Developments

As of the latest update (mid-2023), the PTAB has scheduled oral arguments for the IPR challenges. The district court proceedings are paused pending patent validity decisions, with some motions for summary judgment pending.

Strategic Considerations

  • Sonos aims to leverage patent strength to secure licensing agreements or injunctive relief.
  • Google relies on invalidity defenses via IPR to undermine Sonos’s patent portfolio.
  • Both companies are actively litigating in parallel at the PTAB and district court levels, seeking to influence the outcome through procedural strategies.

Implications for Industry

This case underscores the importance of patent defensibility in wireless audio innovations. Companies should conduct comprehensive prior art searches before patent filings to mitigate invalidity risks. The outcome will likely influence patent enforcement strategies in the smart speaker industry.


Key Takeaways

  • Sonos accuses Google of infringing five wireless speaker patents, seeking injunctive relief and damages.
  • Google contests infringement claims and is challenging patent validity through IPR proceedings.
  • PTAB decisions on patent validity are pivotal, potentially impacting ongoing infringement claims.
  • The litigation exemplifies broader industry conflicts over smart home technology patents.
  • The case highlights the need for rigorous patent prosecution and infringement risk management in high-tech markets.

FAQs

1. What patents are at the center of the Sonos-Google dispute?
Sonos asserts US Patent Nos. 10,990,633; 10,997,322; 11,113,958; 11,138,096; and 11,476,950, focusing on wireless audio synchronization and control.

2. How does the IPR process influence this litigation?
The PTAB’s review of patent validity can invalidate key patents, potentially ending or weakening Sonos’s infringement claims.

3. What are potential outcomes for Sonos if its patents are invalidated?
Invalidation would largely bar Sonos’s claims for damages and injunctive relief and could diminish its leverage against Google.

4. How might this case impact the smart speaker market?
A favorable ruling for Sonos could restrict Google’s product sales or licensing strategies, affecting competitive dynamics.

5. When are the next procedural milestones expected?
PTAB oral arguments are scheduled for late 2023; district court proceedings remain on hold pending patent validity decisions.


References

  1. Sonos, Inc. v. Google LLC, Case No. 3:21-cv-07559 (N.D. Cal.)
  2. PTAB Docket for IPR Proceedings, December 2022
  3. Patent filings and public filings from USPTO

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.